← FDA DRUG APPROVALS

FDA NDA · NDA021571

IQUIX

Sponsor: SANTEN

APPLICATION
NDA021571
TYPE
NDA
ORIGINAL APPROVAL
2004-03-01
LATEST ACTION
2014-12-03
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

IQUIX · ReferenceDiscontinued
LEVOFLOXACIN 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SOLUTION/DROPS · OPHTHALMIC

Approval history

2014-12-03Labeling · Supplement 6 · standard — Label ↗AP
2004-03-01Type 3 - New Dosage Form · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →